Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01357577 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs
A NA study of PTSD and Substance Use Disorders, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 3
- Study locations
NCT01357577: Completed NA study of PTSD and Substance Use Disorders, sponsored by VA Office of Research and Development.
NCT01357577 is a NA study of PTSD and Substance Use Disorders that has completed, run by VA Office of Research and Development. The registered enrollment target is 129 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (57% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01357577, a NA study of PTSD and Substance Use Disorders, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 3
- Study locations
Study Summary
With this research, the investigators hope to learn if cognitive behavioral therapy (CBT) for posttraumatic stress disorder (PTSD) works in people who have both PTSD and problems with drugs or alcohol. In the past, people who had problems with drugs and alcohol were not given treatment for their PTSD. It was believed that PTSD treatment would get in the way of their drug and alcohol treatment. Now the investigators believe that the PTSD symptoms may make it harder to avoid using drugs and alcohol, so the investigators want to see if people can get treatment for both problems at the same time. One hundred-sixty Veterans from 3 sites who have both PTSD and substance use disorders will be in the study. In order to know if the PTSD treatment is helpful, half of the Veterans in this study will receive PTSD treatment and half will continue to get their usual mental health and/or substance abuse treatment. Who gets which treatment will be decided by a random process. The investigators will then compare the 2 groups to see if there are differences in their PTSD symptoms.
Primary Outcome
PTSD symptom severity will be measured by the Clinician Administered PTSD Scale (CAPS). The Clinician Administered PTSD SCALE (CAPS) is the gold standard in PTSD assessment. It is a structured interview that can be used to: Make current (past month) diagnosis of PTSD and Make lifetime diagnosis of PTSD. The minimum value is a 0 and the maximum is 135, the higher the score the worse the outcome, i.e. the more severe PTSD.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive behavioral therapy for PTSD
Study Locations (3)
Florida
- James A. Haley Veterans' Hospital, Tampa, FL - Tampa
New York
- Syracuse VA Medical Center, Syracuse, NY - Syracuse
Vermont
- White River Junction VA Medical Center, White River Junction, VT - White River Junction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2017-10-31 |
| Phase | NA |
What the finished NCT01357577 record still lists
NCT01357577 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Cognitive behavioral therapy for PTSD is the first listed.
NCT01357577 reports a single indexed study location in Florida, New York, Vermont.
Frequently Asked Questions
What is clinical trial NCT01357577 about?
NCT01357577 is a clinical study titled "Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs". With this research, the investigators hope to learn if cognitive behavioral therapy (CBT) for posttraumatic stress disorder (PTSD) works in people who have both PTSD and problems with drugs or alcohol. In the past, people who had problems with drugs and alcohol were not given treatment for their PTS...
What is the current status of trial NCT01357577?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2013-01-01. Estimated completion is 2017-10-31.
What conditions does trial NCT01357577 study?
This clinical trial studies the following conditions: PTSD, Substance Use Disorders.
What interventions are being tested in trial NCT01357577?
The interventions under investigation include: Cognitive behavioral therapy for PTSD (BEHAVIORAL).
Who is sponsoring clinical trial NCT01357577?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01357577 being conducted?
This trial has 3 study locations across Florida, New York, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01357577's enrollment target sits among peer trials
129 50th of 154 higher than 105 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI